Shilajit Market Size, Share Analysis Report | CAGR of 9.6%

Market Overview

The global shilajit market is projected to reach USD 510.7 million by 2035, rising from USD 205.2 million in 2025, at a CAGR of 9.6% from 2026 to 2035. In 2025, Asia Pacific led the market with a 42.6% share, generating USD 87.4 million in revenue. This strong regional position is mainly supported by deep consumer familiarity with Ayurveda, rising herbal supplement use, and expanding wellness-focused retail channels across Asia.

According to the World Health Organization, its 2019 global report covered 179 Member States, and 170 countries—around 88% of WHO Member States—recognize the use of traditional medicine in their health systems.

The industrial landscape is also being strengthened by government policy support. In February 2025, India’s Ministry of Ayush stated in Parliament that the traditional medicine sector attracted ₹590 crore in investment interest through the SCO initiative on Traditional Medicine.

Key Takeaways

• Shilajit Market size is expected to be worth around USD 510.7 Million by 2035, from USD 205.2 Million in 2025, growing at a CAGR of 9.6%.
• Liquid held a dominant market position, capturing more than a 42.8% share.
• General Health held a dominant market position, capturing more than a 32.5% share.
• Online held a dominant market position, capturing more than a 56.2% share.
• Asia Pacific held the dominant position in the global shilajit market, accounting for 42.6% of total revenue, valued at USD 87.4 Mn.

Segmentation Deep Dive

By Form Analysis

In 2025, the liquid form led the shilajit market with a 42.8% share. Its strong performance was mainly supported by rising consumer preference for easy-to-use and quick-absorbing wellness formats. Liquid shilajit is widely favored because it can be mixed easily with water, milk, or daily beverages, making it highly convenient for regular use.

By Application Analysis

In 2025, general health applications accounted for a leading 32.5% share in the shilajit market. This segment remained ahead due to the increasing use of shilajit as an everyday wellness supplement for vitality, immunity, and energy balance.

By Distribution Channel Analysis

In 2025, online channels dominated the shilajit market with a 56.2% share. The segment’s leadership was mainly driven by the continued shift toward digital shopping for wellness and nutraceutical products.

Top Use Cases

Joint health and everyday pain-management supplements: A major use case for shilajit is in daily wellness products aimed at joint comfort, energy balance, and general recovery. This is one reason the ingredient is moving into more mainstream supplement shelves. The broader health backdrop supports this trend: the WHO’s 2019 global report was built from 179 Member States, and WHO says 170 of its 194 Member States have reported use of traditional medicine.

Men’s vitality, testosterone, and fertility support: Shilajit is also widely used in men’s health products, especially for vitality, testosterone support, and reproductive wellness. Clinical evidence gives this use case real commercial weight. In one PubMed-listed randomized controlled trial in healthy men aged 45 to 55 years, shilajit was given at 250 mg twice daily for 90 days, and the study reported significant increases in total testosterone, free testosterone, and DHEAS versus placebo.

Sports nutrition, stamina, and exercise recovery: Another strong use case is in sports nutrition and active lifestyle supplements, where shilajit is marketed for stamina, recovery, and muscle support. A PubMed-listed study examined 8 weeks of supplementation at 250 mg/day and 500 mg/day in the context of fatigue-induced declines in muscular strength and showed enough interest to support continued commercial development in active nutrition. A later study reported that 500 mg/day and 1000 mg/day for 8 weeks increased a biomarker of type 1 collagen synthesis, while a ClinicalTrials.gov entry also shows use of 500 mg/day in an exercise-training setting.

Notable Company Developments

In 2025, Undersun Biomedtech Corp. continued to strengthen its role in the shilajit market through its focus on high-purity Himalayan resin, advanced botanical extraction, and premium wellness-grade formulations. The company’s strong technical base comes from more than 20 years of plant extract manufacturing expertise, built since its 2004 establishment.

In 2025, Alpspure Lifesciences further expanded its position in the shilajit space by focusing on standardized extract production, bulk nutraceutical supply, and high-purity phytochemical processing. A key strength from a market research point of view is its ability to provide shilajit extract standardized to 40% fulvic acid, which serves as an important numerical quality benchmark for B2B supplement manufacturers and functional food brands.

Conclusion

In conclusion, shilajit is steadily evolving from a traditional Ayurvedic ingredient into a globally accepted premium wellness supplement, supported by stronger science, cleaner formulations, and wider international acceptance of traditional medicine.